Investing.com - Vaccinex (NASDAQ: VCNX) reported third quarter EPS of $-1.090, $0.83 worse than the analyst estimate of $-0.260. Revenue for the quarter came in at $20K versus the consensus estimate of $0.
Vaccinex's stock price closed at $0.900. It is down -71.010% in the last 3 months and down -89.860% in the last 12 months.
Vaccinex saw positive EPS revisions and negative EPS revisions in the last 90 days. See Vaccinex's stock price’s past reactions to earnings here.
According to InvestingPro, Vaccinex's Financial Health score is "weak performance".
Check out Vaccinex's recent earnings performance, and Vaccinex's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar